300
Participants
Start Date
July 31, 2005
Primary Completion Date
July 31, 2007
Study Completion Date
February 28, 2011
XIENCE V® Everolimus Eluting Coronary Stent
Drug eluting stent implantation stent in the treatment of coronary artery disease.
TAXUS™ EXPRESS2™ Paclitaxel Eluting Coronary Stent
Drug eluting stent implantation stent in the treatment of coronary artery disease
Wilheminenspital der Stadt Wien, Vienna
A.Z. Middelheim, Antwerp
C.H.R. La Citadelle, Liège
C.H.U. de Liège Sart Tilman, Liège
Segeberger Kliniken GmbH, Bad Segeberg
Herzzentrum Bad Oeynhausen, Bad Oeynhausen
Max Devki Devi Heart & Vascular Institute, New Delhi
Aalborg Sygehus Syd, Aalborg
Århus University Hospital, Aarhus
Rigshospitalet, Copenhagen
Hôpital Cochin, Paris
Clinique Saint Hilaire, Rouen
Clinique Pasteur, Toulouse
Hôpital de Rangueil CHU, Toulouse
Clinique Saint Gatien, Tours
Amper Kliniken AG Klinikum Dachau, Dachau
Herz- und Gefäßzentrum Hamburg, Hamburg
Klinikum Kassel, Kassel
Azienda Ospedaliera Santa Maria Nuova, Reggio Emilia
Amphia Hospital, Breda
St. Antonius Ziekenhuis Nieuwegein, Nieuwegein
Erasmus Medical Center, Rotterdam
Isala Klinieken - Locatie Weezenlanden, Zwolle
The Mercy Hospital, Auckland
Auckland City Hospital, Auckland
National Institute of Cardiology in Warsaw, Warsaw
Vergelegen Mediclinic, Cape Town
Hospital Clinico San Carlos, Madrid
University Hospital Gregorio Maranon, Madrid
Kantonsspital Basel, Basel
R.V. Hôpital Cantonal Universitaire de Geneve, Geneva
Academisch Medisch Centrum, Amsterdam
Lead Sponsor
Abbott Medical Devices
INDUSTRY